Senseonics investor relations material

Senseonics Holdings Inc. is a medical technology company developing and commercializing continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's lead product is the Eversense CGM System that uses a truly implantable sensor containing no display or batter. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.